The basis for future personalized therapy approaches – Machine learning-generated 1-year survival rate, metastatic status and therapy-dependent survival in pancreatic cancer patients

The basis for future personalized therapy approaches – Machine learning-generated 1-year survival rate, metastatic status and therapy-dependent survival in pancreatic cancer patients

François Schneider, Haotian Chen, Uwe Pelzer, Richard G. Compton, Gregor Duwe, Mihnea P. Dragomir, Georg Hilfenhaus, Loredana Vecchione, Annabel Alig, Matthäus Felsenstein, Markus Lerchbaumer, Damian T. Rieke, Marcus Bahra, Ralf Kutsche, Kristina Tschulik, Sebastian Stintzing, Ulrich Keilholz, Christopher C.M. Neumann

European Journal of Cancer, 2026, 234, 116189